FMS · Fresenius Medical Care AG · Analyst Estimates
$22.62
+0.12 (+0.53%)
At close · Oct 28
Return incl. dividend (before tax)
Q2 2026 earnings call transcript
Market Cap
$11.97B
Shares
532.22M
Volume · Oct 28
719.95K
Avg daily vol (3M)
907.81K
Analyst Estimates
Compare analyst forecasts for Fresenius Medical Care AG across metrics and forecast periods.
Estimates are grouped by forecast period, with low, average and high together. A dash means that statistic is not available.
Compiled consensus
These figures are a compiled consensus of analyst forecasts, not a survey the company published itself. Every figure is the statistic the source states; averages are means, never medians.
Captured 2026-10-21 19:29 UTC · Publication dates shown per estimate · 8 metric / period groups
FY ending 2026-12-31
| Metric | Low | Average | High | Analyst count | Average, 7 days ago | Average, 30 days ago | Average, 60 days ago | Average, 90 days ago | Estimates lowered, last 7 days | Estimates lowered, last 30 days | Estimates raised, last 7 days | Estimates raised, last 30 days |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
EPS
EUR
Publication date not stated |
1.93
|
2.07
|
2.22
|
4
|
2.09
|
2.07
|
2.07
|
2.46
|
0
|
0
|
1
|
1
|
|
Revenue
EUR
Publication date not stated |
19.04B
|
19.49B
|
20.16B
|
17
|
— | — | — | — | — | — | — | — |
FY ending 2027-12-31
| Metric | Low | Average | High | Analyst count | Average, 7 days ago | Average, 30 days ago | Average, 60 days ago | Average, 90 days ago | Estimates lowered, last 7 days | Estimates lowered, last 30 days | Estimates raised, last 7 days | Estimates raised, last 30 days |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
EPS
EUR
Publication date not stated |
2.01
|
2.65
|
4.51
|
5
|
2.67
|
3.15
|
3.14
|
3.17
|
0
|
0
|
1
|
1
|
|
Revenue
EUR
Publication date not stated |
19.46B
|
20.15B
|
20.64B
|
16
|
— | — | — | — | — | — | — | — |
Q ending 2026-09-30
| Metric | Low | Average | High | Analyst count | Average, 7 days ago | Average, 30 days ago | Average, 60 days ago | Average, 90 days ago | Estimates lowered, last 7 days | Estimates lowered, last 30 days | Estimates raised, last 7 days | Estimates raised, last 30 days |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
EPS
EUR
Publication date not stated |
0.51
|
0.53
|
0.55
|
2
|
0.51
|
0.51
|
0.50
|
0.57
|
0
|
0
|
1
|
1
|
|
Revenue
EUR
Publication date not stated |
4.85B
|
4.92B
|
5.03B
|
5
|
— | — | — | — | — | — | — | — |
Q ending 2026-12-31
| Metric | Low | Average | High | Analyst count | Average, 7 days ago | Average, 30 days ago | Average, 60 days ago | Average, 90 days ago | Estimates lowered, last 7 days | Estimates lowered, last 30 days | Estimates raised, last 7 days | Estimates raised, last 30 days |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
EPS
EUR
Publication date not stated |
0.41
|
0.53
|
0.65
|
2
|
0.55
|
0.55
|
0.55
|
0.61
|
0
|
0
|
1
|
1
|
|
Revenue
EUR
Publication date not stated |
4.94B
|
5.20B
|
5.60B
|
5
|
— | — | — | — | — | — | — | — |
Key facts
CIK
1333141
CUSIP
358029106
13F (30d)
70 filings
66 filers
Visit website
Investor relations